Advertisement

Topics

Prediction of antibiotic resistance: time for a new preclinical paradigm?

09:14 EDT 31 Jul 2017 | Nature Publishing

Risk assessment for the development of antibiotic resistance against a new drug candidate is of paramount importance in preclinical development. In this Opinion article, Sommer et al. propose a new preclinical paradigm for the prediction of antibiotic resistance.

Original Article: Prediction of antibiotic resistance: time for a new preclinical paradigm?

NEXT ARTICLE

More From BioPortfolio on "Prediction of antibiotic resistance: time for a new preclinical paradigm?"

Quick Search
Advertisement
 

Relevant Topics

MRSA (methicillin-resistant Staphylococcus aureus)
MRSA (methicillin-resistant Staphylococcus aureus) is a family of bacteria with resistance to one or more major antibiotics. There are currently 17 different strains of MRSA. Two particular strains, EMRSA15 and EMRSA16  account for 96% of MRSA blood...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Searches Linking to this Story